Concepedia

Mark Lovern

ML

10

Publications

529

Citations

10

H-Index

1997

Active since

Affiliations

Certara (United States)(Current)

Research Triangle Park Foundation

Integra LifeSciences (United States)

North Carolina State University

GlaxoSmithKline (United States)

Mark Lovern is an author at Certara (United States) specializing in human metabolism, bioanalysis, and toxicology.

Top concepts

Publications per year

1997–2022

10

Publications

10

Ceftazidime‐Avibactam Population Pharmacokinetic Modeling and Pharmacodynamic Target Attainment Across Adult Indications and Patient Subgroups

Jianguo Li, Mark Lovern, Michelle Green et al. · Clinical and Translational Science · 2018 · 99 citations · Full text

Pharmacokinetics and pharmacodynamics of Abelacimab (MAA868), a novel dual inhibitor of Factor XI and Factor XIa

B. Alexander Yi, Debra Freedholm, Nancy Widener et al. · Journal of Thrombosis and Haemostasis · 2021 · 92 citations · Full text

Identification of benzene oxide as a product of benzene metabolism by mouse, rat, and human liver microsomes

Mark Lovern · Carcinogenesis · 1997 · 62 citations · Full text

, , +23

Pharmacokinetic study of different dosing regimens of levonorgestrel for emergency contraception in healthy women

E. Johansson, Vivian Brache, Frank Álvarez et al. · Human Reproduction · 2002 · 56 citations · Full text

A Pharmacodynamic Markov Mixed-Effects Model for Determining the Effect of Exposure to Certolizumab Pegol on the ACR20 Score in Patients With Rheumatoid Arthritis

Benoît Lacroix, Mark Lovern, Armel Stockis et al. · Clinical Pharmacology & Therapeutics · 2009 · 53 citations

Rows per page

1–5 of 10